Latest News

As global markets navigate a mix of economic signals, the Asian market has been particularly influenced by developments in U.S.-China trade relations and domestic policy shifts. For investors interested in smaller or emerging companies, penny stocks—despite their somewhat dated name—remain a relevant area for potential growth. By focusing on those with robust financial health, these stocks can offer unexpected value and stability amidst broader market fluctuations.

When close to half the companies in Norway have price-to-earnings ratios (or "P/E's") below 12x, you may consider Tomra...

Readers hoping to buy CeoTronics AG ( FRA:CEK ) for its dividend will need to make their move shortly, as the stock is...

AfroCentric Investment Corporation Limited's ( JSE:ACT ) price-to-sales (or "P/S") ratio of 0.1x might make it look...

Shareholders might have noticed that Loomis AB (publ) ( STO:LOOMIS ) filed its third-quarter result this time last...

TUI AG ( ETR:TUI1 ), is not the largest company out there, but it saw significant share price movement during recent...

Spotify Technology (SPOT) delivered standout results this earnings season, with net profit margins reaching 8.3%, up sharply from 4.6% previously, and EPS growth an impressive 100.4% year-over-year compared to its 5-year average of 56% per year. The company’s forward guidance calls for continued momentum, forecasting annual EPS growth of 26.8% and revenue growth of 12%, both outpacing the broader US market. With current profitability trends and no major risks identified in the latest filings,...

SunCoke Energy (SXC) faces a tough road ahead, with earnings projected to decline by 2.3% per year and revenue expected to contract at an even sharper rate of 8.5% annually over the next three years. The company’s net profit margin has slipped to 3.5%, down from 4.4% the year before, reflecting a negative turn in recent profitability after five years of strong average annual profit growth. As a result, investors are likely viewing SunCoke’s earnings update as a move from years of expansion...

Gladstone Commercial (GOOD) is forecasting earnings growth of 20.6% per year, outpacing the US market’s expected 16% annual growth rate. Over the last five years, the company’s earnings have grown at an impressive average rate of 41.7% each year, and earnings quality remains high. Revenue growth is projected at 5.5% per year, trailing the broader US market average of 10.5%. Net profit margin stands at 5.4%, just below last year’s 5.7%. With shares currently trading at $10.7, below both...

Coterra Energy (CTRA) reported earnings that accelerated 33% over the past year, outpacing the company’s five-year average growth of 11.5% per year. Net profit margins improved from 23.4% to 24.4%, indicating stronger profitability. With earnings forecast to grow at 10.63% annually and revenue also projected to advance by about 10% each year, investors have reason to be optimistic about continued performance momentum. See our full analysis for Coterra Energy. Next, we will see how these...

Wondering if Evonik Industries might be a bargain or a value trap? You're not alone. Plenty of investors are watching for signs the stock is undervalued. Despite some ups and downs, the share price has dipped 3.3% this week and is down 14.4% so far this year, signaling shifting market sentiment and possibly fresh opportunities. Market chatter has picked up around Evonik’s portfolio restructuring and sustainability initiatives, both of which have caught the attention of analysts and industry...

Sequans Communications (SQNS) is currently unprofitable, but has managed to reduce losses by 42.6% per year over the past five years. Revenue is expected to grow 25.61% annually, well ahead of the US market average growth rate of 10.5%. However, the company is still forecast to remain in the red over the next three years. Investors looking at the setup will see attractive top-line growth prospects and a price-to-sales ratio of 2.7x, which is notably lower than the semiconductor industry...

Caribou Biosciences (CRBU) is attracting fresh attention after releasing positive interim data from phase 1 trials of its lead CAR-T therapies, vispacabtagene regedleucel and CB-011, for lymphoma and multiple myeloma. See our latest analysis for Caribou Biosciences. Momentum has picked up for Caribou Biosciences following its positive clinical trial updates and upcoming pivotal studies, but recent volatility is hard to ignore. The stock’s 1-day share price return dropped 10.7% after the data...

Compass (COMP) remains unprofitable, but over the last five years the company has steadily narrowed its losses by an average of 21.1% each year. Looking forward, earnings are forecast to grow at a rapid 61.21% per year, with analysts expecting Compass to reach profitability within the next three years. With annual revenue projected to grow at 10.8%, outpacing the broader US market’s 10.5% estimate, the equity story for Compass is tilted toward rewards due to anticipated strong profit and...

Wondering if TriMas is trading for less than it's worth? You're not alone, as investors are always keen to spot undervalued opportunities before the market catches on. TriMas has seen some sharp moves lately, with the stock dropping 11.1% over the last week and 10.7% in the past month, even though it's still up 41.3% year-to-date. Market watchers are buzzing about recent industry developments and shifting economic conditions that are shining a spotlight on companies like TriMas. These...

Genius Sports (GENI) continues to operate at a loss, but over the last five years, it has managed to cut annual losses by 26%. While the company remains unprofitable, analysts project impressive earnings growth of 100.48% per year and expect profitability within three years. With revenue forecast to climb 15% annually, which is higher than the broader US market forecast of 10.5%, investors have a front-row seat to a transition story fueled by rapid top-line expectations and progressively...

CompoSecure (CMPO) remains unprofitable, with net losses deepening at a rate of 66.8% per year over the past five years. Still, analysts forecast earnings to grow 168.7% annually and expect the company to cross into profitability within the next three years. Revenue is projected to climb 37.6% a year, which far outpaces the US market average of 10.5%. See our full analysis for CompoSecure. The next section examines how these headline numbers align with well-known market narratives,...

Denny's (DENN) net profit margin slipped to 2.2% from last year's 3.9%, with annual earnings declining by 11.9% over the past five years and recent negative growth that makes year-on-year comparisons tough. Investors may be watching closely as revenue is only expected to grow at 3.4% per year, lagging well behind the broader US market’s projected 10.5%. However, despite these lackluster trends and a relatively rich valuation, forecasts are calling for a sharp rebound in earnings, with a...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...

Solid profit numbers didn't seem to be enough to please Barwa Real Estate Company Q.P.S.C.'s ( DSM:BRES ) shareholders...

Last week, you might have seen that Alma Media Oyj ( HEL:ALMA ) released its third-quarter result to the market. The...

Saudi Research and Media Group ( TADAWUL:4210 ) shareholders might be concerned after seeing the share price drop 11...

For many, the main point of investing in the stock market is to achieve spectacular returns. While not every stock...

There wouldn't be many who think Saudi Ground Services Company's ( TADAWUL:4031 ) price-to-earnings (or "P/E") ratio of...